CASP3 and lung cancer: Continuing this trend, another ruthenium compound, named complex-6, was shown to activate caspase-9 in dose- and time-dependent manner, along with up-regulation of BAX and cleaved-caspase-3, and downregulation of Bcl-2 in NCI-H460 lung cancer cells.